Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›International Business Machines Stock (IBM)
Track International Business Machines stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
Read the latest TheStreet Pro articles mentioning International Business Machines, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
140 articlesDaily Diary Mentions
10 mentionsUpside, Downside Movers in the Morning IBM Faces a Test Double top? That would be a bearish signal. IBM ($IBM) still has not filled the gap created back in early July. That said, IBM has retaken its 21-day EMA today. If it holds, the swing crowd will be back on board. The 50-day SMA would be up next. That would entice the pros to increase …
Read in context ›More Tales From Nvidia: The Furious Race to Get IPOs Done and My Objections to ARR (Issue #242!) It looks like Broadcom ($AVGO) is already back for another fix. It really makes me wonder how there is enough savings in the world to do this, although the Treasury market is telling you there isn’t: Broadcom CDS Explodes As It Seeks Up To $100 Billion In Massive Off-Balance Sheet Debt Deal At any rate, …
Read in context ›IBM Trims Outlook IBM ($IBM) has trimmed its outlook. Position: None
Read in context ›Thinking Further on IBM Yes, I’ve added to IBM ($IBM) on today’s weakness. Readers will see that after falling out of bed late this past winter, the shares of IBM had developed a rectangle pattern with a $258 pivot over the following three-month period. The stock broke out of that pattern in response to the above news flow. In doing so, …
Read in context ›




